Gain insight from an eSource study observing digitally received data as far back as 2007 to just before initial guidance was released by the U.S. FDA in 2013.

As technology continues to evolve, learn how IRT systems can no longer be implemented into the fabric of the organization, but rather need to ebb and flow with the needs of clinical trials.

Unearth how modern software development in clinical research technology will shape the industry's future.

Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

The industry anticipates a transformative shift towards embedding RBQM as a foundational practice in modern clinical research as a means to enhance trial efficiency and safety.

This paper highlights why the industry is moving towards RBQM and how sponsors can build a scalable approach that protects trial participants, upholds study integrity, and increases operational efficiencies.

As technology continues to evolve, learn how IRT systems can no longer be implemented into the fabric of the organization, but rather need to ebb and flow with the needs of clinical trials.

Streamlined supply chain operations alleviate staff workload and significantly reduce IP waste. With the right partners, you can create a fully optimized, cost-effective supply chain strategy.

This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.

Global standards and AI are transforming clinical research. Learn why mastering ICH E6(R3) and risk-based compliance is critical for data integrity and future success.

Artificial intelligence is reshaping regulatory medical writing by accelerating document development while maintaining compliance and scientific rigor, creating faster, regulator-ready submissions without compromising quality.

AI is reshaping clinical trials by accelerating patient recruitment, optimizing protocol design, and improving data quality—driving faster, more efficient, and more inclusive research outcomes.

Seasoned clinical research expert and advocate of data ethics Angela Radcliffe discusses how the industry can enhance the lives of both patients and clinical trial sites.

The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.

Discover how a specialized site payment solution can streamline your clinical trials, enhance site engagement, and deliver measurable financial benefits.